D360 Express with IDBS ActivityBase Connector

D360 Express with ActivityBase connector is ideal for ActivityBase users who want quick and easy, single-point access to retrieve, analyze and share scientific data. It’s the only turnkey solution that seamlessly integrates ActivityBase with D360 Express to provide leading edge capabilities while minimizing IT cost and maintenance.

Read More
Topics:

D360 Pre-clinical

D360 removes the major roadblocks that preclinical scientists encounter when answering questions related to safety data by making the data easily available, in a format that is readily accessible and usable. As a result, answers are arrived at quickly and easily, and scientists are enabled to ask questions that were previously impossible to ask.

Read More
Topics:

D360 IT Maintenance Overhead

Providing scientists with access to project data and tools to analyze and collaborate is vitally important to improving the effectiveness of rational, data-driven research. This capability must be provided without undue burden or cost on already stretched IT resources. D360™ is a scientific informatics tool that meets these criteria.

Read More
Topics:

Cross-Study Search and Analysis of Pre-clinical Safety Data

Certara’s D360 enables scientists to focus on uncovering trends in their data, without the pain of figuring out how to access it. A global top 10 pharmaceutical company, devoted to discovering new medicines and new technologies for managing personal health, engaged in an initiative to better address cross-study analysis of pre-clinical safety data. Toxicologists, pathologists, […]

Read More
Topics:

Streamlined, Self-Service Access to Scientific Data

D360 enables scientists to easily access, analyze, and visualize chemical and biological data, enhance scientific capabilities. A small biotechnology company dedicated to the research and development of small molecule therapeutics engaged in an initiative to better address access and analysis of chemical and biological data by its scientists. Scientists at this company use IDBS’ ActivityBase®, […]

Read More
Topics:

Optimized Pre-clinical Informatics for Faster, Surer Development Decisions

A top 40 pharmaceutical company enhanced data access and decision support for pre-clinical safety with Certara’s D360 data access and analysis application and a specialized CDISC SEND-based database. Pre-clinical scientists at a top 40 pharmaceutical company faced delays of a day or more for data collation and transformation with each incremental data update received from […]

Read More
Topics:

Replacing In-House Informatics for Cost Savings and Enhanced Knowledge Access

Discovery team lowers IT costs and improves end-user functionality by standardizing on Certara’s D360 Drug Discovery Platform A multi-national pharmaceutical company had developed a custom informatics system, providing all scientists in its discovery organization with access to essential research data. While information access was well-served by the tool, over time, a long list of new […]

Read More
Topics:

Analyses Requiring Hours In The Past Reduced To Minutes

Medivir sees a fast return on its investment — time savings and enhanced informativeness of data activities The discovery arm of Medivir®, a mid-size, Swedish pharmaceutical company, sought an updated informatics infrastructure to improve the efficiency and flexibility of its data analysis and reporting. The group’s existing in-house tools could only create reports in a […]

Read More
Topics:

Speeding the Iterative Drug Design process

In this paper, we explore the issues in the effective use of modern pharmaceutical data mining applications. We discuss the development and capabilities that were built into the Discovery 360° application to address these issues, as part of Wyeth Pharmaceuticals Next Generation IT project (NextGen). Wyeth found that simplifying data access and integration of data […]

Read More
Topics:

Managing Pre-clinical Study Data as a Strategic Asset

In this webinar, David Lowis, D. Phil. of Certara, makes the case for adopting a solution that allows immediate access, visualization and analysis of pre-clinical data for optimized decision making, while leveraging the FDA mandated CDISC-SEND data standard. Joining Dr. Lowis will be Stuart Horowitz, PhD, President of Institutional Services at WIRB-Copernicus Group. Dr. Horowitz […]

Read More
Topics:
Learn More
LinkedIn